NIR Stimulation and Cellular Autophagy Effects

The 2016 Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi for his discoveries of the mechanisms behind autophagy — a fact that underscores just how central this process is to cellular health. Autophagy (from the Greek for "self-eating") is the cell's primary quality-control pathway: it systematically identifies, engulfs, and degrades damaged proteins, dysfunctional organelles, and intracellular pathogens, then recycles their molecular building blocks for new biosynthesis. Epidemiological data suggest that chronically suppressed autophagy is a feature of aging, neurodegenerative conditions, metabolic dysfunction, and accelerated tissue deterioration — making its modulation a high-priority target in wellness and longevity research.

What is less widely known is that near-infrared (NIR) light — the same modality used in photobiomodulation (PBM) — has been shown to activate autophagic pathways in multiple tissue types. This opens an intriguing avenue for non-pharmacological support of one of biology's most important housekeeping systems.

At the molecular level, autophagy is orchestrated by a network of autophagy-related genes (ATGs) and two master regulatory kinases that act in opposition to each other:

• mTORC1 (mechanistic target of rapamycin complex 1): A nutrient and energy sensor that suppresses autophagy when the cell is well-fed and ATP-replete. mTORC1 phosphorylates ULK1 (unc-51-like autophagy-activating kinase 1), keeping it inactive.
• AMPK (AMP-activated protein kinase): An energy-deficit sensor that activates autophagy when AMP:ATP ratios rise, such as during caloric restriction or exercise. AMPK directly activates ULK1 by phosphorylating Ser317 and Ser777.

Once ULK1 is active, it initiates phagophore formation through the Beclin-1/VPS34 complex, which generates phosphatidylinositol-3-phosphate at the nascent autophagosome membrane. The expanding phagophore engulfs cytoplasmic cargo, seals into an autophagosome, fuses with a lysosome, and degrades its contents with lysosomal hydrolases. The resulting amino acids, fatty acids, and nucleotides are exported for reuse in biosynthesis.

NIR irradiation activates autophagy through at least three converging mechanisms, all rooted in its effects on mitochondrial function:

1. AMPK activation via transient ATP modulation: Although PBM ultimately increases net ATP production, the initial photochemical event — activation of cytochrome c oxidase and displacement of inhibitory NO — creates a brief energetic perturbation that elevates AMP:ATP ratios transiently. This activates AMPK, which then phosphorylates ULK1 to initiate autophagic flux.
2. Mild ROS-driven Beclin-1 upregulation: The small, transient ROS burst generated during PBM oxidizes specific cysteine residues in Beclin-1's regulatory domains, releasing it from its inhibitory interaction with Bcl-2 and enabling autophagosome biogenesis.
3. SIRT1 deacetylase activation: PBM has been shown to elevate NAD⁺ levels — a consequence of enhanced mitochondrial electron flow. Elevated NAD⁺ activates the longevity-associated deacetylase SIRT1, which deacetylates and activates multiple ATG proteins including ATG5, ATG7, and Beclin-1.

These pathways are not redundant; they act additively and may explain why PBM-induced autophagy is robust across diverse cell types including neurons, cardiomyocytes, and skeletal muscle cells.

Within the broader autophagy framework, mitophagy — the selective degradation of damaged or depolarized mitochondria — deserves special attention in the context of NIR stimulation. Dysfunctional mitochondria with collapsed membrane potential are tagged by the PINK1-Parkin pathway: PINK1 (PTEN-induced kinase 1) accumulates on the outer membrane of depolarized mitochondria, phosphorylates ubiquitin, and recruits the E3 ligase Parkin, which ubiquitinates outer membrane proteins to mark the organelle for autophagic engulfment.

NIR irradiation promotes mitophagy by simultaneously enhancing healthy mitochondrial function (which sharpens the distinction between functional and dysfunctional organelles) and activating the broader autophagic machinery. The net result is a leaner, more efficient mitochondrial pool with higher per-unit ATP output — a concept sometimes called mitochondrial quality control. Studies in neuronal cell lines have shown that 810 nm irradiation significantly increases LC3-II puncta (autophagosome markers) and decreases p62 accumulation (a surrogate for autophagic flux) within 4 hours of a single session (Poyton & Ball, 2011).

The research base linking NIR stimulation to autophagy induction is still emerging relative to PBM's better-established effects on ATP and inflammation, but the existing data are compelling:

While human clinical trials with autophagy as a primary outcome are sparse, the preclinical convergence across cell types and species provides a strong mechanistic rationale for NIR-induced cellular housekeeping in vivo.

Autophagy induction by NIR may follow a slightly different optimal dose window than simple ATP enhancement. Based on the preclinical literature, the following parameters appear most relevant:

• Wavelength: 810–850 nm. Longer NIR wavelengths penetrate deeper and are more likely to modulate AMPK activity in skeletal and cardiac muscle, which are high-autophagy tissues.
• Fluence: 3–8 J/cm² per session. Very low doses may be insufficient to trigger AMPK; very high doses (above 20 J/cm²) may saturate or downregulate autophagic signaling.
• Timing relative to activity: Some evidence from exercise science suggests that autophagy induction is greatest when NIR is applied during or immediately after physical activity, when AMPK is already elevated and autophagic machinery is primed.
• Frequency: 3–5 sessions per week. Autophagy is a rhythmic process with natural oscillation; daily continuous stimulation may blunt the response over time compared to an intermittent schedule.
• Session duration: 10–15 minutes per target area, adjusting for power density to achieve the target fluence range.

For individuals interested in supporting cellular quality control through daily routine, the CIRIUS NIR LED healthcare device provides a convenient means of delivering 850 nm near-infrared light to targeted tissue areas. The 850 nm wavelength aligns with the preclinical evidence for deep-tissue AMPK activation and SIRT1-mediated autophagic pathway support described above.

From a practical wellness perspective, applying the CIRIUS device post-exercise or in the evening — when the body's natural autophagic rhythms are typically more active — may provide a useful complement to other longevity-focused practices such as time-restricted eating, adequate sleep, and regular aerobic exercise. The CIRIUS device is positioned as a non-medical wellness tool and makes no claims regarding disease prevention or treatment. It is intended to support daily physical wellness, including circulation, muscle relaxation, and recovery — not to replace clinical care for any diagnosed medical condition.

Responsible use of NIR LED for autophagy-supportive wellness includes the following considerations:

• Eye protection: Always close or shield the eyes from direct NIR exposure. Even sub-laser NIR at 850 nm can cause discomfort or long-term retinal stress with repeated unprotected exposure.
• Photosensitizing medications: Consult a physician before using any PBM device if taking tetracyclines, fluoroquinolones, psoralens, or amiodarone.
• Immunosuppressed or post-transplant individuals: Because autophagy is intimately connected with immune function and cell turnover, individuals on immunosuppressive regimens should seek medical clearance before adding PBM to their routine.
• Active malignancy: Autophagy plays complex and sometimes pro-tumorigenic roles in cancer biology. Individuals with active malignancies should not use PBM devices without explicit oncologist guidance.
• Thyroid gland: Avoid direct irradiation over the thyroid, as NIR may influence thyroid hormone synthesis in ways that are not yet fully characterized.
• Not a substitute for medical care: NIR-mediated autophagy support is a wellness concept, not a clinical intervention. Persistent symptoms, cognitive decline, or muscle degeneration require professional medical evaluation.